Global Troponin Market Growth 2025-2031

The global Troponin market size is predicted to grow from US$ 1653 million in 2025 to US$ 2776 million in 2031; it is expected to grow at a CAGR of 9.0% from 2025 to 2031.

Troponin, or the troponin complex, is a complex of three regulatory proteins (troponin C, troponin I, and troponin T) that is integral to muscle contraction in skeletal muscle and cardiac muscle, but not smooth muscle.



Discussions of troponin often pertain to its functional characteristics and/or to its usefulness as a diagnostic marker or therapeutic target for various heart disorders in particular as a highly specific marker for myocardial infarction or heart muscle cell death.



A troponin test measures the levels troponin T or troponin I proteins in the blood. These proteins are released when the heart muscle has been damaged, such as occurs with a heart attack.

Leading producers in the sector are Abbott, Roche and Siemens Healthcare, with revenue ratios of 28.303%, 21.249% and 10.063% in 2019.

LP Information, Inc. (LPI) ' newest research report, the “Troponin Industry Forecast” looks at past sales and reviews total world Troponin sales in 2024, providing a comprehensive analysis by region and market sector of projected Troponin sales for 2025 through 2031. With Troponin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Troponin industry.

This Insight Report provides a comprehensive analysis of the global Troponin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Troponin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Troponin market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Troponin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Troponin.

This report presents a comprehensive overview, market shares, and growth opportunities of Troponin market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Troponin I (TnI)
Troponin T (TnT)

Segmentation by Application:
Myocardial Infarction
Acute Coronary Syndrome
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Abbott
Roche
Siemens Healthcare
Beckman Coulter
Biomerieux
Mitsubishi
Quidel
Getein Biotech
Improve Medical
Response Biomedical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Troponin market?

What factors are driving Troponin market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Troponin market opportunities vary by end market size?

How does Troponin break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.